ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Intentional and unintentional non-adherence in hypertension: psychometric validation, adherence-complexity phenotyping and causal mediation analysis from the VATAHTA Study.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-adherence to antihypertensive therapy remains a major barrier to blood pressure (BP) control globally. The behavioural distinction between intentional (INA) and unintentional non-adherence (UNA) is underexplored in low- and middle-income countries. We aimed to validate the Spanish MMAS-8, identify adherence-complexity phenotypes, and assess the mediating role of adherence between regimen complexity and BP control. In this multicenter, cross-sectional study (2022-2024), 1144 hypertensive patients from Argentina were evaluated. Adherence was assessed using the Spanish MMAS-8. Psychometric validation included Cronbach's alpha and principal component analysis. INA and UNA were classified by domain-based response patterns. K-means clustering was applied to MMAS-8 items and regimen complexity (number of drugs, daily doses). Mediation analysis tested the indirect effect of adherence. The MMAS-8 showed acceptable reliability (α = 0.78) and a unidimensional structure. Full adherence was observed in 41.1%. Among non-adherent patients, 38.5% were INA, 33.6% UNA, and 27.9% mixed. Four phenotypes were identified: (1) high adherence/low complexity; (2) very low adherence/simple regimens; (3) moderate adherence/intermediate complexity; (4) low adherence/high complexity. Adherence significantly mediated the effect of complexity on BP control (β = 0.004; p < 0.001), while the direct effect was non-significant. Compared with phenotype 1, phenotype 2 showed 58% lower odds of control (OR 0.42; 95% CI 0.29-0.61) and phenotype 4 showed 32% lower odds (OR 0.68; 95% CI 0.49-0.94). The Spanish MMAS-8 is valid for this population. Adherence-complexity phenotypes reflect structural and behavioural barriers. Tailored interventions should address INA and UNA using adherence profiling, fixed-dose combinations, and social support.
Indexed as
Identifiers
41402595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.